IMAGE Skincare Vol.U.Lift
IMAGE Skincare launches first and only GLP-1 Skin Rebound Complex intentionally formulated to combat the specific facial changes caused by rapid weight loss.
According to research by Juniper (published in The Times), around 11 per cent of women aged 30 to 75 said they were taking a weight-loss jab. If we extrapolate these results across the UK, this means that about two million of the almost 20 million women within that age group are using the drugs.
The rise of weight-loss medication like Ozempic, Wegovy, and Mounjaro has also seen an increase in ‘Ozempic Face’ which is the noticeable facial changes that can occur due to rapid weight loss, which includes lost volume due to muscle and connective tissue loss, decrease in skin proteins like collagen and elastin, all leading to accelerated visible skin ageing. These changes have thus led to a surge in demand for cosmetic treatments like facial fillers.
To help customers combat this phenomenon at home, IMAGE skincare and plastic surgeon Dr. Marc Ronert, have formulated Vol.U.Lift the first and only multidimensional formula that works in 4D to address specific skin concerns that occur with GLP-1 usage to improve the appearance of facial skin.
Dr. Marc Ronert says, “As a plastic surgeon, I am seeing firsthand the rapid rise in GLP-1 usage among patients and the subsequent long-term side effects that directly impact overall skin health. GLP-1 induced skin ageing is a new phenomenon that is affecting patients in different ways.
However, to date there are no targeted solutions that address the distinct range of skin concerns that accompany these treatments. This is why I developed VOL.U.LIFT , the first and only GLP-1 4D Skin Rebound Complex intentionally formulated to combat the specific facial changes that result from GLP-1 usage, addressing the appearance of facial deflation, sagging, crepey skin texture, dehydration, and wrinkles.
Using next generation ingredients combined with our proprietary, patent pending XOSM Technology, this breakthrough formulation corrects these facial changes while nourishing the skin’s barrier for a solution that can be used as a standalone product or accompanying professional procedures for radiant, younger-looking skin.
This clinically proven formulation is guaranteed to fill a widespread consumer need, solidifying VOL.U.LIFT as the superior topical solution for GLP- 1 induced skin ageing. We are excited to partner with you and ultimately become the leading topical treatment in your arsenal to address and treat GLP-1 facial skin concerns.”
Vol.U.Lift is available to purchase direct from Wigmore Medical online and in-store, and clinics nationwide, without prescription, for £105. Find your nearest clinic at https://volulift.co.uk/.
